VIT.AX

Healthcare Drug Manufacturers - Specialty & Generic

Vitura Health Limited

A$0.02

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

12.59M

Avg Volume

364,185

EPS

-A$0.01

52W High

A$0.07

52W Low

A$0.02

Div. Yield

0.0%

Valuation

Forward P/E

0.47

P/B Ratio

0.29

P/S Ratio

0.10

EV/EBITDA

-13.60

EV/Revenue

0.18

Margins

Gross Margin 21.7%

Operating Margin (3.1%)

Net Margin (3.3%)

EBITDA Margin (1.3%)

Growth & Returns

Revenue Growth (YoY)

3.1%

Return on Equity

(9.7%)

Return on Assets

(1.7%)

Liquidity & Leverage

Current Ratio

0.79

Quick Ratio

0.61

Debt / Equity

0.38

Total Cash

5.35M

Total Debt

16.40M

About

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a therapy clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; Adaya, which provides hybrid formulations and Australian-cultivated products; Candor Medical, that provides care to patients; and inscape, which offers crafted formulations for individual needs. In addition, the company engages in the supply of MDMA and synthetic psilocybin for therapeutic purposes. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. Vitura Health Limited was incorporated in 2018 and is based in South Yarra, Australia.